Milos Miljkovic

Company: Cartesian Therapeutics

Job title: Chief Medical Officer

Seminars:

Keynote Presentation: Clinical & Mechanistic Perspective on Bringing Cell Therapies to Autoimmune Disease 10:00 am

Introducing RNA engineering for cell therapy Demonstrating deep and durable responses in patients receiving Descartes-08 without lymphodepletion or inpatient administration Insight into mechanisms behind Cartesian Therapeutics’ lead asset, Descartes-08Read more

day: Conference Day Two P1

Panel Discussion: Discussing the Latest on the Need for Lymphodepletion in Cell Therapies to Improve Patient Access & Limit Therapeutic Side Effects 9:00 am

Identify why lymphodepletion has been used in autoimmune cell therapies Examine the impact of lymphodepletion on patient recruitment and accessibility Consider the advantages and opportunities to remove preconditioning from therapiesRead more

day: Conference Day Two P1